IDENTIFICATION OF TRICYCLIC ANALOGS RELATED TO ELLAGIC ACID AS POTENT SELECTIVE TYROSINE PROTEIN-KINASE INHIBITORS

被引:39
|
作者
DOW, RL [1 ]
CHOU, TT [1 ]
BECHLE, BM [1 ]
GODDARD, C [1 ]
LARSON, ER [1 ]
机构
[1] ONCOGENE SCI INC,MANHASSET,NY 11030
关键词
D O I
10.1021/jm00040a015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The plant-derived natural product ellagic acid (1) has recently been identified as a potent, though nonselective, inhibitor of the tyrosine-specific protein kinase pp60(src). This report details efforts directed toward the identification of tricyclic structures related to ellagic acid, with enhanced specificity for inhibition of pp60(src) over other protein kinases. Phenanthridinone and carbazole core structures were selected for investigation, since N-functionalization allows for the synthesis of numerous analogs which can be utilized to probe enzyme-inhibitor interactions. These ring systems were prepared via a general sequence of biaryl bond formation followed by cyclization to form the desired tricyclic ring systems. N-Alkylation, -acylation, or -sulfonylation and deprotection with boron tribromide afford the target tetraphenolic phenanthridinones 5 and carbazoles 9. Several analogs from both of these series have potencies comparable to that of 1 and exhibit substantially enhanced selectivities for inhibition of pp60(src) relative to protein kinase A (PKA), a serine/threonine protein kinase. Carbazole-based analogs 9j,m,p are submicromolar inhibitors of pp60(src), with potency for the target tyrosine kinase comparable to that of ellagic acid (1), however with 2 orders of magnitude greater selectivity versus that for PKA. As seen for ellagic acid, members of the phenanthridinone-based series (e.g., 5a) exhibited inhibition of pp60(src) in a manner which is partial mixed noncompetitive with respect to ATP, while analogs in the carbazole series (e.g., 9a) inhibit pp60(src) in an ATP competitive manner.
引用
收藏
页码:2224 / 2231
页数:8
相关论文
共 50 条
  • [21] Potent and selective inhibitors of the FGF receptor-1 tyrosine kinase
    Westwell, AD
    DRUG DISCOVERY TODAY, 2001, 6 (07) : 379 - 379
  • [22] Discovery of potent and selective reversible Bruton?s tyrosine kinase inhibitors
    Qiu, Hui
    Ali, Zahid
    Bender, Andrew
    Caldwell, Richard
    Chen, Yi-Ying
    Fang, Zhizhou
    Gardberg, Anna
    Glaser, Nina
    Goettsche, Anja
    Goutopoulos, Andreas
    Grenningloh, Roland
    Hanschke, Bettina
    Head, Jared
    Johnson, Theresa
    Jones, Christopher
    Jones, Reinaldo
    Kulkarni, Shashank
    Maurer, Christine
    Morandi, Federica
    Neagu, Constantin
    Poetzsch, Sven
    Potnick, Justin
    Schmidt, Ralf
    Roe, Katherine
    Follis, Ariele Viacava
    Wing, Carolyn
    Zhu, Xiaohua
    Sherer, Brian
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 40
  • [23] Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors
    Raeppel, Stephane L.
    Gaudette, Frederic
    Nguyen, Hannah
    Beaulieu, Normand
    Wang, James
    Maroun, Christiane
    Besterman, Jeffrey M.
    Vaisburg, Arkadii
    INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY, 2012, 2012
  • [24] Identification of a novel series of potent RON receptor tyrosine kinase inhibitors
    Raeppel, Stephane
    Gaudette, Frederic
    Mannion, Michael
    Claridge, Stephen
    Saavedra, Oscar
    Isakovic, Ljubomir
    Deziel, Robert
    Beaulieu, Normand
    Beaulieu, Carole
    Dupont, Isabelle
    Nguyen, Hannah
    Wang, James
    Macleod, A. Robert
    Maroun, Christiane
    Besterman, Jeffrey M.
    Vaisburg, Arkadii
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) : 2745 - 2749
  • [25] SELECTIVE-INHIBITION OF TYROSINE PROTEIN-KINASE BY A SYNTHETIC MULTISUBSTRATE ANALOG
    BAGINSKI, I
    COMMERCON, A
    TOCQUE, B
    COLSON, G
    ZERIAL, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) : 1324 - 1330
  • [26] KELATORPHAN AND RELATED ANALOGS - POTENT AND SELECTIVE INHIBITORS OF LEUKOTRIENE A(4) HYDROLASE
    PENNING, TD
    ASKONAS, LJ
    DJURIC, SW
    HAACK, RA
    YU, SS
    MICHENER, ML
    KRIVI, GG
    PYLA, EY
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (21) : 2517 - 2522
  • [27] Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents
    Ghosh, Sutapa
    Liu, Xing-Ping
    Zheng, Yaguo
    Uckun, Fatih M.
    CURRENT CANCER DRUG TARGETS, 2001, 1 (02) : 129 - 140
  • [28] Total Synthesis of Amino-Functionalized Calphostin Analogs as Potent and Selective Inhibitors of Protein Kinase C (PKC)
    Kim, Hyoyeon
    Song, Choon-Ho
    Kim, Dae-Hyuk
    Jung, Nam-Gin
    Lee, Seung-Jae
    Kim, Beom-Tae
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2016, 37 (10): : 1586 - 1592
  • [29] Potent, selective inhibitors of protein tyrosine phosphatase 1B
    Xin, ZL
    Oost, TK
    Abad-Zapatero, C
    Hajduk, PJ
    Pei, ZH
    Szczepankiewicz, BG
    Hutchins, CW
    Ballaron, SJ
    Stashko, MA
    Lubben, T
    Trevillyan, JM
    Jirousek, MR
    Liu, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (11) : 1887 - 1890
  • [30] Identification of Ellagic acid analogues as potent inhibitor of protein Kinase CK2:A chemopreventive role in oral Cancer
    Srivastava, Rashi
    Akthar, Salman
    Sharma, Rolee
    Mishra, Sanjay
    BIOINFORMATION, 2015, 11 (01) : 21 - 26